Tagged with RTS

Egypt Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both locally and abroad. He also gives insights into Egypt’s new consolidated approach of targeting other African countries for exports, uniting…

Egypt Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export strategy, targeting markets in the Gulf Region and South East Asia.   Production costs are rising, and pricing pressures continue,…

Turkey Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898 million in 2017.   These charts show both the volume and value of imported and locally-produced drugs in the Turkish pharma market between 2010 and 2017. TL 13.33 billion (USD 2.57…

Turkey Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the chemical and pharmaceutical sectors in Turkey’s exports. He underscores pharma’s role in Turkey’s ‘Vision 2023’ and explains how IMMIB is helping the sector increase its export potential.   With our 29…

Turkey Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to harness their geographic positioning and export to developed and developing markets alike.   We did not shy away from entering the most advanced healthcare ecosystems. Barış Özyurtlu, General Manageger, Berko Ilac.…

Malta Malta has the second largest pharma trade balance per capita in the EU, the tenth in total, and was the continent’s fastest growing pharma exporter between 2001 and 2016. Malta acts a flight hub for southern Europe, with 35,000 international departures and arrivals per annum. Doing business in Malta is…

India Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly increasing their efforts to develop stronger footprints in strategic emerging market such as Brazil, Russia and some Asian and African…

Poland The value of Poland’s pharmaceutical exports shot from USD 501 million in 2005 to USD 3.475 billion in 2015, a total growth of an astounding 590% and a compound annual growth rate of 21%. Most exports go to Europe (80%) but Asian markets are becoming increasingly important to Poland and…

India Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub and gives us his assessment of the recent plateauing of Indian exports as well as an overview of the new…

Poland Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the space for growth in the future, especially via the reimbursement of parallel imported products. Furthermore, he touches on the relationship…

Poland Colm Murphy, general plant manager of Anpharm, a key European production site for the Servier group, highlights major investments in recent years, such as the state-of-the-art QC Lab, and his strategy to increase the plant’s exports. Additionally, he discusses the growing importance of the company’s CDMO activities and the steps…

Canada Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs.   Key areas of expenditure in Canadian medtech: diagnostic imaging stands as the single largest therapeutic area served.   Canadian medical device export destinations; the US is far and away the largest market for Canadian…